A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
Public ClinicalTrials.gov record NCT03823391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Double-Dummy, Active Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Subjects With Moderate to Severe Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the safety, tolerability, and efficacy of ABBV-3373 in participants with moderately to severely active rheumatoid arthritis (RA) on background methotrexate (MTX) compared with adalimumab.
Study identification
- NCT ID
- NCT03823391
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Interventions
- ABBV-3373 Drug
- Placebo for ABBV-3373 Drug
- Adalimumab Drug
- Placebo for adalimumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 27, 2019 (Actual)
- Primary completion
- Apr 8, 2020 (Actual)
- Completion
- Aug 26, 2020 (Actual)
- Last update posted
- Jul 19, 2021
2019 – 2020
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheum Assoc of North Alabama /ID# 213626 | Huntsville | Alabama | 35801 | — |
| AZ Arthritis and Rheum Researc /ID# 208515 | Phoenix | Arizona | 85032 | — |
| C.V. Mehta MD, Med Corporation /ID# 213068 | Hemet | California | 92543 | — |
| Robin K. Dore MD, Inc /ID# 213045 | Tustin | California | 92780 | — |
| Inland Rheum & Osteo Med Grp /ID# 213044 | Upland | California | 91786 | — |
| Suncoast Clinical Research /ID# 213973 | New Port Richey | Florida | 34652 | — |
| Arthritis Center, Inc. /ID# 213972 | Palm Harbor | Florida | 34684 | — |
| W. Broward Rheum Assoc Inc. /ID# 211017 | Tamarac | Florida | 33321 | — |
| BayCare Medical Group, Inc. /ID# 213935 | Tampa | Florida | 33614-7101 | — |
| Institute of Arthritis Researc /ID# 213043 | Idaho Falls | Idaho | 83404 | — |
| PRN Professional Research Network of Kansas, LLC /ID# 213046 | Wichita | Kansas | 67205 | — |
| Clinvest Research LLC /ID# 215451 | Springfield | Missouri | 65810-2607 | — |
| Duke Early Phase Research Unit (DCRI) /ID# 213212 | Durham | North Carolina | 27710 | — |
| Paramount Medical Research Con /ID# 209042 | Middleburg Heights | Ohio | 44130 | — |
| STAT Research, Inc. /ID# 213933 | Vandalia | Ohio | 45377-9464 | — |
| West Tennessee Research Inst /ID# 208838 | Jackson | Tennessee | 38305 | — |
| PCCR Solution /ID# 215457 | Colleyville | Texas | 76034 | — |
| Trinity Universal Research Association /ID# 209167 | Plano | Texas | 75024-5283 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03823391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03823391 live on ClinicalTrials.gov.